Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors

NCT02135562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2017-09-20

No results posted yet for this study

Summary

This pilot clinical trial studies protein-sparing modified fast (PSMF) intervention for weight loss in obese endometrial cancer survivors. The PSMF is a diet that is very low in carbohydrates and calories, designed to induce fast, safe weight loss. The diet consists of only lean meats (beef, pork, poultry, and seafood) in amounts adequate to meet protein requirements based on the individual's body weight. The PSMF may help endometrial cancer survivors achieve significant weight loss, reduce the risk of chronic disease, and improve quality of life.

Conditions

Interventions

DIETARY_SUPPLEMENT

Dietary Intervention

Follow the Protein-Sparing Modified Fast (PSMF) intervention. This diet has participants consume enough lean beef, pork, poultry, and seafood to provide 1.2 grams of protein per kilogram of their obesity adjusted ideal body weight.

OTHER

Informational Material

Receive carbohydrate reintroduction handout

OTHER

Dietary Education

Receive education on nutrition label reading for carbohydrates

DIETARY_SUPPLEMENT

Weight Maintenance

weight maintenance diet consists of gradual addition of previously eliminated carbohydrate containing food groups to the high protein PSMF diet. During weight maintenance, consumption of non-starchy vegetables is unlimited

OTHER

Average score of Obesity and Weight-Loss Quality of Life Questionnaire

Participants will take a tailored quality of life questionnaire. These scores will be averaged and a group mean reported. Higher scores indicate greater quality of life.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Kimberly Resnick · Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-08
Primary Completion
2017-04-19
Completion
2017-04-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135562 on ClinicalTrials.gov